Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Tofacitinib
Other

Tofacitinib

Tracked across 1 events · 6 articles · First seen Jun 10, 2026 · Last active Jun 10, 2026

Sentiment
0
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
4 0
Regulatory
Concord Biotech gets USFDA Tofacitinib approval
Impact: Tofacitinib is the drug that received USFDA approval, opening up a $500 million market opportunity for Concord Biotech.
Jun 10, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Tofacitinib live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.